Literature DB >> 22270847

Lexical access speed is significantly correlated with the return to professional activities after awake surgery for low-grade gliomas.

Sylvie Moritz-Gasser1, Guillaume Herbet, Igor Lima Maldonado, Hugues Duffau.   

Abstract

Awake surgery with intraoperative brain mapping is highly recommended for patients with diffuse low-grade gliomas in language areas, to maximise the extent of resection while preserving the integrity of functional networks and thus quality of life. The picture-naming test "DO.80" is the gold standard for language assessment before, during, and after surgery. Cognitive functioning is correlated with quality of life, itself linked with return to work. Our objective was to evaluate the significance of measuring naming speed, and its correlation with the return to professional activities. Two complementary studies are reported. In the first retrospective study, eleven patients were examined post-operatively. Five patients were selected because they were not able to resume their professional activities ("no return group 1"). They were compared with a control group of six patients who are working normally after surgery ("return group 1"). The eleven patients performed a global language and neuropsychological assessment, with a post-operative median follow-up of 35 months. In a subsequent prospective study, twelve patients were examined pre-operatively and post-operatively. Six patients who were not able to return to work ("no return group 2") were compared with a control group of six patients who were working normally after the surgery ("return group 2"). The twelve patients performed a pre and post-operative language assessment, with a median follow-up of 9 months. Our results show, for the first time, that naming speed is significantly correlated with a major criterion of quality of life: the return to professional activities. There were no differences between the two groups regarding other measures of cognition. Assessing naming times, and not only naming accuracy, is essential in the management of low-grade glioma patients, before, during, and after surgery, to preserve their quality of life by resuming their previous professional activity. Our results have fundamental implications concerning the comprehension of language processing and its relationship with cognitive functioning.

Entities:  

Mesh:

Year:  2012        PMID: 22270847     DOI: 10.1007/s11060-011-0789-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Timed picture naming in seven languages.

Authors:  Elizabeth Bates; Simona D'Amico; Thomas Jacobsen; Anna Székely; Elena Andonova; Antonella Devescovi; Dan Herron; Ching Ching Lu; Thomas Pechmann; Csaba Pléh; Nicole Wicha; Kara Federmeier; Irini Gerdjikova; Gabriel Gutierrez; Daisy Hung; Jeanne Hsu; Gowri Iyer; Katherine Kohnert; Teodora Mehotcheva; Araceli Orozco-Figueroa; Angela Tzeng; Ovid Tzeng
Journal:  Psychon Bull Rev       Date:  2003-06

2.  Predictors of picture naming speed.

Authors:  F Xavier Alario; Ludovic Ferrand; Marina Laganaro; Boris New; Uli H Frauenfelder; Juan Segui
Journal:  Behav Res Methods Instrum Comput       Date:  2004-02

3.  Timed action and object naming.

Authors:  Anna Szekely; Simonetta D'Amico; Antonella Devescovi; Kara Federmeier; Dan Herron; Gowri Iyer; Thomas Jacobsen; Analía L Arévalo; Andras Vargha; Elizabeth Bates
Journal:  Cortex       Date:  2005-02       Impact factor: 4.027

4.  Slowed lexical access is uniquely associated with positive and disorganised symptoms in schizophrenia.

Authors:  Michael J Minzenberg; John H Poole; Sophia Vinogradov; Gregory K Shenaut; Beth A Ober
Journal:  Cogn Neuropsychiatry       Date:  2003-05       Impact factor: 1.871

5.  Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas.

Authors:  Martin L Waagemans; David van Nieuwenhuizen; Monica Dijkstra; Miriam Wumkes; Clemens M F Dirven; Sieger Leenstra; Jaap C Reijneveld; Martin Klein; Lukas J A Stalpers
Journal:  Neurosurgery       Date:  2011-07       Impact factor: 4.654

6.  Facets and determinants of quality of life in patients with recurrent high grade glioma.

Authors:  A R Giovagnoli; A Silvani; E Colombo; A Boiardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

7.  The role of the output phonological buffer in the control of speech timing: a single case study.

Authors:  L Cohen; A C Bachoud-Levi
Journal:  Cortex       Date:  1995-09       Impact factor: 4.027

8.  Category specific access dysphasia.

Authors:  E K Warrington; R McCarthy
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

9.  Preferential brain locations of low-grade gliomas.

Authors:  Hugues Duffau; Laurent Capelle
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

10.  Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere.

Authors:  Hugues Duffau; S T Peggy Gatignol; Emmanuel Mandonnet; Laurent Capelle; Luc Taillandier
Journal:  J Neurosurg       Date:  2008-09       Impact factor: 5.115

View more
  24 in total

1.  A minimal standardization setting for language mapping tests: an Italian example.

Authors:  Adrià Rofes; Vânia de Aguiar; Gabriele Miceli
Journal:  Neurol Sci       Date:  2015-04-08       Impact factor: 3.307

Review 2.  Brain connectomics applied to oncological neuroscience: from a traditional surgical strategy focusing on glioma topography to a meta-network approach.

Authors:  Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2021-02-09       Impact factor: 2.216

3.  Ask the experts: Maintaining neurological function in brain tumor resection.

Authors:  Hugues Duffau
Journal:  CNS Oncol       Date:  2013-01

Review 4.  Language mapping with verbs and sentences in awake surgery: a review.

Authors:  Adrià Rofes; Gabriele Miceli
Journal:  Neuropsychol Rev       Date:  2014-04-16       Impact factor: 7.444

Review 5.  Surgical oncology for gliomas: the state of the art.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Nat Rev Clin Oncol       Date:  2017-11-21       Impact factor: 66.675

6.  Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?

Authors:  Emmanuel Mandonnet; Michel Wager; Fabien Almairac; Marie-Helene Baron; Marie Blonski; Christian F Freyschlag; Fabio Barone; Denys Fontaine; Johan Pallud; Monika Hegi; Catarina Viegas; Maria Zetterling; Giannantonio Spena; John Goodden; Geert-Jan Rutten; Luc Taillandier; Nicolas Foroglu; Amélie Darlix; Miran Skrap; Juan Martino; Gord von Campe; Caterina Madadaki; Etienne Gayat; Philip de Witt Hamer; Santiago Gil Robles; Silvio Sarubbo; Thomas Santarius; Lorenzo Bello; Marie-Therese Forster; Hugues Duffau
Journal:  Neurooncol Pract       Date:  2017-01-17

Review 7.  Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible?

Authors:  Hugues Duffau
Journal:  Neurosurg Rev       Date:  2017-11-06       Impact factor: 3.042

Review 8.  MRI-Guided stereotactic laser ablation for epilepsy surgery: Promising preliminary results for cognitive outcome.

Authors:  Daniel L Drane
Journal:  Epilepsy Res       Date:  2017-09-23       Impact factor: 3.045

9.  A valid alternative for in-person language assessments in brain tumor patients: feasibility and validity measures of the new TeleLanguage test.

Authors:  Elke De Witte; Vitória Piai; Garret Kurteff; Ruofan Cai; Peter Mariën; Nina Dronkers; Edward Chang; Mitchel Berger
Journal:  Neurooncol Pract       Date:  2018-07-17

10.  Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy.

Authors:  Daniel L Drane; David W Loring; Natalie L Voets; Michele Price; Jeffrey G Ojemann; Jon T Willie; Amit M Saindane; Vaishali Phatak; Mirjana Ivanisevic; Scott Millis; Sandra L Helmers; John W Miller; Kimford J Meador; Robert E Gross
Journal:  Epilepsia       Date:  2014-12-08       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.